Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?

Expert Opinion on Investigational Drugs
C F DeaconJens J Holst

Abstract

Inhibitors of the enzyme dipeptidyl peptidase IV (DPP IV) are of increasing interest to both diabetologists and the pharmaceutical industry alike, as they may become established as the next member of the oral antidiabetic class of therapeutic agents, designed to lower blood glucose and, possibly, prevent the progressive impairment of glucose metabolism in patients with impaired glucose tolerance and Type 2 diabetes. DPP IV has become a focus of attention for drug design, as it has a pivotal role in the rapid degradation of at least two of the hormones released during food ingestion, a property that has warranted the design of inhibitor-based drugs. At the molecular level, DPP IV cleaves two amino acids from the N-terminus of the intact, biologically active forms of both so-called incretin hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (formerly known as gastric inhibitory polypeptide), resulting in truncated metabolites, which are largely inactive. Inhibition of the enzyme, therefore, is thought to increase levels of the active forms of both incretin hormones, culminating in an increase in insulin release after a meal, in a fully glucose-dependent manner. DPP IV inhibitors combine several fea...Continue Reading

References

Mar 1, 1989·Diabetes·G C WeirJ F Habener
Dec 24, 1997·Diabetes Care·M K GutniakB Ahrén
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·D MarguetN Wagtmann
Sep 27, 2000·Biochimica Et Biophysica Acta·A Stöckel-MaschekK Neubert
Jun 8, 2001·Biochemical and Biophysical Research Communications·T NagakuraI Tanaka
Nov 1, 2002·The Journal of Biological Chemistry·Yazhou LiDaniel J Drucker
Dec 7, 2002·Diabetes/metabolism Research and Reviews·Jens Juul Holst

❮ Previous
Next ❯

Citations

Sep 29, 2005·Current Diabetes Reports·Clifford J Bailey
Jun 28, 2005·Biochimica Et Biophysica Acta·Hans-Ulrich DemuthRaymond A Pederson
Jun 2, 2005·Bioorganic & Medicinal Chemistry Letters·I-Lin LuWeir-Torn Jiaang
Mar 3, 2007·Southern Medical Journal·Patrick J Boyle, John Zrebiec
Apr 26, 2008·Diabetes, Obesity & Metabolism·Kasper AaboeJens Juul Holst
Sep 5, 2007·International Journal of Clinical Practice. Supplement·C Mathieu, K Bollaerts
Sep 5, 2007·International Journal of Clinical Practice. Supplement·J Green, M Feinglos
Sep 5, 2007·International Journal of Clinical Practice. Supplement·S Del Prato
Feb 1, 2010·Therapeutic Advances in Endocrinology and Metabolism·Glenn Matfin, Richard E Pratley
Jan 21, 2012·The Review of Diabetic Studies : RDS·Carolyn F Deacon, Bo Ahrén
Jan 14, 2012·Drug Metabolism and Pharmacokinetics·Jin Sook SongMyung Ae Bae
Dec 19, 2013·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Amin R SolimanMahmoud A Soliman
Mar 15, 2014·Clinical Drug Investigation·Dongseong ShinKyung-Sang Yu
Sep 13, 2007·Journal of Endocrinological Investigation·G CrepaldiG Paolisso
Jun 20, 2014·Future Medicinal Chemistry·Yang Liu, Yongzhou Hu
May 9, 2014·Cell Biochemistry and Biophysics·Chiranjib ChakrabortyGovindasamy Agoramoorthy
Jun 10, 2011·Expert Opinion on Pharmacotherapy·Sreevidya Subbarayan, Mark Kipnes
Sep 24, 2008·Expert Opinion on Investigational Drugs·Jonathan Kent ReynoldsR Keith Campbell
Aug 31, 2006·Expert Opinion on Emerging Drugs·Brian D GreenClifford J Bailey
Jan 31, 2008·Expert Opinion on Investigational Drugs·Matthew Coghlan, Brendan Leighton
Jul 1, 2010·Expert Opinion on Drug Discovery·Sheraz Gul, Philip Gribbon
Jul 25, 2006·Expert Opinion on Investigational Drugs·Claudio GonzálezGuillermo Di Girolamo
Jan 16, 2008·Current Medical Research and Opinion·Itamar RazMaria Alba
Apr 5, 2007·Current Medical Research and Opinion·Richard E Pratley, Afshin Salsali
Apr 5, 2007·Current Medical Research and Opinion·Claresa Levetan
Jan 23, 2016·Der Internist·J J Meier
Jun 18, 2010·Allergologia et immunopathologia·A KargiliB Bozkurtl
Dec 23, 2008·Diabetes Research and Clinical Practice·Viswanathan MohanKeith D Kaufman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.